Standardization
of Poly-herbal Formulations: A Comprehensive Review
Jadhav Santosh1,
Sawale Jyotiram2
1Department of Pharmaceutics, Sahyadri College of Pharmacy,
Methwade, Sangola- 413307.
2Department of Pharmacognocy, Sahyadri College of
Pharmacy, Methwade, Sangola- 413307.
*Corresponding Author E-mail: jadhavsan88@gmail.com
ABSTRACT:
Herbal medicines
are not a simple task since many factors influence the biological efficacy and
reproducible therapeutic effect. Herbal products have gained increasing
popularity in the last decade, and are now used by approximately 20% of the
population or it is however a known fact that over 80% of the world population
depends on herbal medicines and product for healthy living. WHO specific
guidelines for the assessment of the safety, efficacy and quality of herbal
medicines as a prerequisite for global harmonization are of utmost importance.
WHO specific guidelines for the assessment of the safety, efficacy and quality
of herbal medicines as a prerequisite for global harmonization are of utmost
importance. This review seeks to enlighten stakeholders in herbal medicine on
the need to establish quality parameters for collection, handling, processing
and production of herbal medicine as well as employ such parameters in ensuring
the safety of the global herbal market.
KEYWORDS: Standardization,
WHO, polyherbal, USFDA, Quality Control.
INTRODUCTION:
The use of herbs as medicine is the oldest form of
healthcare known to humanity and has been used in all cultures throughout
history. Early humans recognized their dependence on nature for a healthy life
and since that time humanity has depended on the diversity of plant resources
for food, clothing, shelter, and medicine to cure myriads of ailments. One of the
major problems faced by the herbal industry is the unavailability of rigid
quality control profiles for herbal materials and their formulations. Primitive
people learned by trial and error to distinguish useful plants with beneficial effects
from those that were toxic or inactive, and also which combinations or
processing methods had to be used to gain consistent and optimal results. Even
in ancient cultures, tribal people methodically collected information on herbs
and developed well-defined herbal pharmacopeias.1-2
Standardization
of herbal drugs is not an easy task as numerous factors influence the bio
efficacy and reproducible therapeutic effect. In order to obtain quality oriented
herbal products, care should be taken right from the proper identification of
plants, season and area of collection and their extraction and purification
process and rationalizing the combination in the case of polyherbal drugs. In
India, the department of Ayush, Government of India, launched a central scheme
to develop a standard operating procedures for the manufacturing process to
develop pharmacopeial standards for ayurvedic preparations.
Medicinal plants are widely distributed throughout the
world but most abundantly in tropical countries. It is estimated that about 25%
of all modern medicines are directly or indirectly derived from higher plants.
Thus, herbal medicine has led to the discovery of a number of new drugs, and
non-drug substances. The subject of herbal drug standardizations massively wide
and deep. There is so much to know and so many seemingly contradictory theories
on the subject of herbal medicines and their relationship with human physiology
and mental function. India needs toexplore the medicinally important plants. This
can be achieved only if the herbal products are evaluated and analyzed using sophisticated
modern techniques of standardization.3-4
Need of standardization:5-7
In the global perspective, there is a shift towards the
use of medicine of herbal origin, as the dangers and the shortcoming of modern medicine
are getting more apparent. It is the cardinal
responsibility of the regulatory authorities to ensure that consumers get the
medication, which guarantees purity, safety, potency and efficacy. The
regulatory authorities rigidly follow various standards of quality prescribed for
raw materials and finished products in pharmacopoeias, formularies and
manufacturing operation through statutory imposed good manufacturing practices.
These procedures logically would apply to all types of medication whether
included in modern system of medicine or one of the traditional systems.
It is the
cardinal responsibility of the regulatory authorities to ensure that the
consumers get the medication, which guaranteed the purity, Safety, potency and
efficacy. This duty is discharged by regulatory authorities by rigidity
following various standards of quality prescribed for raw materials and
finished products in pharmacopoeias controlling manufacturing formula through
the use of formularies and manufacturing operation through statutory imposed
“Good manufacturing practices”. Herbal products has been enjoying renaissance
among the customers throughout the world.
Due to complex
nature and inherent variability of the constituents of the plant based drugs,
it is difficult to establish quality control parameter and modern analytical
technique are expected to help in circumventing this problem. The quality
control of crude drugs and herbal formulations is of paramount importance in
justifying their acceptability in modern system of
medicine. To achieve the desired benefit from herbal preparations, an individual
must take the required dose over a certain length of time. Although it is generally
believed that most herbal preparations are safe for consumption, some herbs like
most biologically active substances could be toxic with undesirable side effects.
Therefore, in case of herbal drugs and product, the word “standardization”
should encompass entire field of study from cultivation of medicinal plant to
its clinical application. Plant material and herbal remedies derived from them
represent substantial portion of global market and in this respect
internationally recognized guidelines for their quality control are necessary.
WHO has emphasized the need to ensure quality control of medicinal plant
products by using modern technique and by applying suitable parameters and
standards? In order to overcome certain inevitable shortcoming of the
Pharmacopoeial monograph other quality control measures must be explored.
Standardization of raw
materials includes: -8-11
Authentication- Each and every step has to be
authenticated, area of the collection, parts of the plant collection, the
regional situation, as phytomorphology botanical identity, microscopic and
histological analysis(characteristic features of cell walls, cell contents,
starch grains, calcium oxalate crystals, hairs, fibers, vessels etc.) Several
studies of the histological parameters are list of palisade ratio, vein islet
number, vein termination, stomatal number, stomatal index, trichomes, stomata,
quantitative microscopy, taxonomic identity, foreign matter. Loss on drying, swelling
index, foaming index, ash values and extractive values, Chromatographic and
spectroscopic evaluation, Determination of heavy metals, pesticide residues, Microbial
contamination, Radioactive contamination. The parameter stability of herbal
formulations that includes pharmacognostic parameters, physico-chemical
parameters, phyto-chemical parameters, microbiological assay, chromatographic
analysis.
Fig.
1 A schematic representation of herbal drug standardization
Pharmacognostic evaluation:
It includes color, odor, taste, texture, size, shape,
microscopical characters, and histological parameters.
Physico-chemical parameters:
Each monograph contains detailed botanical, macro-scopic
and microscopic descriptions of the physical characteristics of each plant that
can be used to ensure both identity and purity. Each description is accompanied
by detailed illustrations and photographic images which provide visual
documentation of accurately identified material. It includes foreign matter, total ash,
acid-insoluble ash, swelling and foaming index, assay, successive extractive values,
moisture content, viscosity, PH, Disintegration time, friability, hardness, flow
capacity, flocculation, sedimentation, alcohol content.
Chemical parameters:
This covers screening, isolation, identification and purification
of the chemical components. Chemical analysis of the drug is done to assess the
potency of vegetable material in terms of its active principles. The chemical screening
or tests may include colour reaction test, which help to determine the identity
of the drug substance and possible adulteration. It includes limit tests, chemical
tests etc.
Chromatographic and
spectroscopic analysis:
Critical to compliance with any monograph standard is
the need for appropriate analytical methods for determining identity, quality,
and relative potency. There area plethora of analytical methods available. However,
it is often difficult to know which is the most appropriate to use, but
critical among know analytical tools in monograph standardization is
chromatography.
Full and accurate characterization of plant material
requires a thorough physical examination. Microscopic analyses of plants are
invaluable for assuring the identity of the material and as an initial screening
test for impurities. It includes TLC, HPLC, HPTLC, GC, UV, IR, FT-IR, AAS,
LC-MS, GC-MS, fluorimetry etc.
Microbiological parameters:
Pharmacological activity of certain drugs has been
applied to evaluate and standardize them. The assays on living animal and on their
intact or isolated organs can indicate the strength of the drug or their preparations.
These assays are known as Biological assays or Bioassay. It includes the full
content of viable, total mould count, total coli forms count. Limiters can be used
as a quantitative tool or semi-quantitative to determine and control the amount
of impurities, such as reagents used in the extraction of various herbs,
impurities ships directly from the manufacturing and solvents etc.
Purity determination:
Each monograph includes standards for purity and other
qualitative indices already mentioned above.
Who Guidelines for Herbal
formulations:12-14
The USFDA has issued draft guidance for botanical
products. The regulatory approach is based on intended use of botanical – as dietary
supplement, cosmetic or drug and status of botanical – marketed in US, marketed
outside US or not marketed at all. The guideline is fairly exhaustive and
pragmatic. The data requirements depend on several factors.
A. Traditional herbal medicines or currently marketed botanical
products, because of their extensive though uncontrolled use in humans, may require
less preclinical information to support initial clinical trials than would be expected
for synthetic or highly purified drugs.
B. Requirements for Investigational New Drug (IND) applications
of botanicals legally marketed in the United States as dietary supplements or
cosmetics
C. Requirements for botanical product that has not been
previously marketed in the United States or anywhere in the world.
D. Clinical trials of botanical products
E. Documentation for early trials (IND)
F. Exclusive marketing rights
1.
Quality
control of crude drugs material, plant preparations and finished products.
2.
Stability
assessment and shelf life.
3.
Safety
assessment; documentation of safety based on experience or toxicological
studies.
4.
Assessment
of efficacy by ethno medical in formations and biological activity evaluations.
5.
The
bioactive extract should be standardized on the basis of active principles or major
compounds along with the chromatographic fingerprints (TLC, HPTLC, HPLC, and
GC).
Methods of Standardisation:15-17
Methodology is divided in to following for the better
indulgent:
1.
Process
standardization
2.
Rasausadhis
standardization
3.
Overview
on herbal drug standardization
4.
Polyherbal
standardization
5.
DNA
fingerprinting technique
6.
Techniques
in extraction of herbals
7.
Phytosomes/
pharmacosomes: A novel drug delivery system for herbal drugs
8.
Instrumental
techniques for herbal drug standardization & identification
9.
Herbal
nanomedicines standardization
10. Global status of the regulatory guidelines
for herbal medicines
11. Recent advancement in the methodology for
the standardization of herbal medicines.
Critical Factors Affecting
the Quality Control of Herbal Drugs:18, 19
1. Microscopic evaluation
2. Foreign matter
3. Ash content
4. Heavy metals
5. Microbial contaminants and aflatoxins
6. Pesticide residues
7. Radioactive contamination
8. Analytical methods
9. Validation
10. Labelling of herbal products
CONCLUSION:
The subject of
herbal drug standardization is massively wide and deep. There is so much to
know and so much seemingly contradictory theories on the subject of herbal
medicines and its relationship with human physiology and mental function. Herbal
drug standardization is massively wide and deep. Standardization of herbal drugs
comprises total information and controls to essentially guarantee consistent
composition of all herbals including analytical operations for identification,
markers and assay of active principles. Knowledge of Ayurveda is now being
imparted through institution, colleges, and hospitals and through ancient
treatises. This has necessitated the establishment of standards for ayurvedic
drugs and formulations so as to ensure proper use of the medicines so prepared
for the benefit of the end user without any unwarranted complications. Now a day’s newer and advanced methods are
available for the standardization of herbal drugs like fluorescence quenching,
the combination of chromatographic and Spectrophotometric methods, biological
assays, use of biomarkers in fingerprinting etc. Bioassay can play an important
role in the standardization of herbal drugs and can also become an important
quality control method as well as for proper stability testing of the product. Thus
standardization is needed to establish quality control parameters for each
traditional drug before it is released for use without the fear of toxicity and
contamination. There is need for development of techniques which includes both
traditional methods of evaluation and modern methods of evaluation. This will
improve the quality of the drug and also motivates the practitioners to get
more involved in the standardization process. It is recommended that various government agencies should follow a more universal approach to
herbal quality by adopting the WHO guidelines and also developing monographs
using the various quality parameters outlined above.
REFERENCES:
1. Barnes
J, Anderson LA, Phillipson JD Herbal medicine. 3rd Edition,
Pharmaceutical Press, London. 2007: 1-23.
2. WHO.
Quality Control Methods for Medicinal Plant Materials. World Health
Organization, Geneva, 1992.
3. WHO.
The International Pharmacopeia, Quality Specifications for Pharmaceutical
Substances, Excipients, and Dosage forms, 3rded. World Health
organization Geneva, (3): 1988.
4. De
Smet. PAGM. Drug Information Journal, 33, 1999, 717-724.
5. WHO.
Guidelines for the appropriate use of Herbal Medicines. WHO Regional
publications, Western pacific series No 3, WHO Regional office for the Western
Pacific, Manila, 1998.
6. WHO.
Guidelines for the Assessment of Herbal Medicines. WHO Technical Report Series,
No. 863. World Health Organization, Geneva, 1996.
7. Watson
DG. Pharmaceutical Analysis. Churchill Livingstone, Edinburgh, 1999.
8. Sagar
Bhanu PS, Zafar R and Panwar R: Herbal drug standardization. The Indian
Pharmacist 4(35): 2005; 19-22.
9. Vaidya
ADB, Devasagayam TPA. Current status of herbal drugs in India: An overview. J
Clin Biochem, 41(1): 2007, 1-11.
10. Sagar
Bhanu, P.S., Zafar R., Panwar R. “Herbal drug standardization”, The Indian Pharmacist., 4(35), 2005,
19-22.
11. Patel,
P.M., Patel N.M., Goyal, R.K. “Evaluation of marketed poly-herbal
antidiabetic formulations uses biomarker charantin”, The Pharma Review, 4(22); 2006:113.
12. Patel,
P.M., Patel, N.M., Goyal, R.K. “Quality control of herbal products”, The Indian Pharmacist, 5(45); 2006:
26-30.
13. Neeli
RE, Kamta PN, Pradeep KS. Standardization Strategies for Herbal Drugs-An
Overview. Research J. Pharm. and Tech, 1(4); 2008: 310-312.
14. Charavarthy
BK. Standardization of Herbal Products. Indian Journal of Natural Product, 9:
1993; 23-26
15. Bhutani,
K.K. “Herbal medicines an enigma and challenge to science and directions for
new initiatives”, Indian Journal of
Natural Products, 19(1); 2003:3-8.
16. P.S.
Mukherjee: Quality control of herbal drugs, 2ndedition. 455- 456.
17. http://www.reddybams.page.tl/MALLASINDHUR.htm
(Accessed 12th April 2012).
18. Krishna
gopalshastri, Rasendra sarasangraha, Ajmer: Krishna gopal ayurved bhavan,
kaleda. 1/157-158, 2006: 59.
19. Kokate
CK and Purohit AP: Nirali Prakashan, text book of pharmacognosy, 34th
edition: 97-132.
Received
on 22.03.2016 Modified on 05.04.2016
Accepted
on 28.04.2016 ©A&V Publications All right reserved
Res. J. Pharmacognosy and Phytochem. 2016; 8(2): 85-89
DOI: 10.5958/0975-4385.2016.00016.9